Peter Forsberg, MD

home / authors / peter-forsberg-md

Articles

Looking Forward: Advice for Clinicians and Discussing Unmet Needs in the R/R MM Landscape

October 19th 2022

Dr. Joshua Richter and Dr. Peter Forsberg close their discission with thoughtful advice for clinicians regarding the current and future treatment of patients with R/R MM.

Practical Considerations for Reducing Risk and Providing Supportive Care

Peter Forsberg, MD;Joshua Richter, MD

October 12th 2022

Insights on supportive care measures to minimize or counter common adverse effects for patients with R/R MM taking selinexor-based therapies

Dosing Strategies and Adverse Events in Patients Treated with Selinexor

Peter Forsberg, MD;Joshua Richter, MD

October 12th 2022

Discourse centered around dosing strategies for selinexor-based therapies.

Key Trial Data Supporting the Use of Selinexor in Patients with R/R MM

Joshua Richter, MD;Peter Forsberg, MD

October 4th 2022

Two subject matter experts discuss keystone trials supporting the use of Selinexor in patients with R/R MM, each with unique dosing structures and different selinexor-based combinations.

An Overview of Treatment Options Available for Patients with R/R MM

Joshua Richter, MD;Peter Forsberg, MD

October 4th 2022

Opening their discussion on relapsed/refractory multiple myeloma, Joshua Richter, MD and Peter Forsberg, MD review options for treatment sequencing, initiating treatment, and the mechanism of action for selinexor.